In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...

It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...

Learn more about anxiety medications. The first line of treatment for depression is antidepressant medication. Some people may need a combination of drugs to best manage their condition.

Depression affects millions of Americans every year, and the challenges can feel even more overwhelming during the holiday ...

Focusing treatments for depression and anxiety to gut cells instead of brain cells may help people feel better without side effects.

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

Psilocybin-assisted therapy, which involves using the active ingredient from "magic mushrooms," could benefit roughly 5 ...

Research reveals new connections between the gut and brain, suggesting more targeted depression and anxiety treatments, and a ...

Relmada halted Phase 3 trials of NMDA receptor blocker for depression but will continue its early psilocybin program while ...

A systemic review found that, on average, 36 percent of people living with schizophrenia met the criteria for treatment ...